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Abstract
Background:  The proteinase-activated receptor 4 (PAR4) is a G-protein-coupled receptor
activated by proteases such as thrombin and trypsin. Although activation of PAR4 has been shown
to modulate rat gastrointestinal motility, the rat PAR4 sequence was unknown until now. This
study aimed to identify the rat PAR4 cDNA.
Results: The cDNA coding for the rat PAR4 homologue was cloned from the duodenum.
Northern blots demonstrated a 3.0 kb transcript in the duodenum. Protein homology with mouse
and human counterparts was 90% and 75% respectively. PAR4 is expressed predominantly in the
esophagus, stomach, duodenum and the spleen. When expressed in COS cells, PAR4 is activated
by trypsin (1 nM), thrombin (50 nM), mouse PAR4 specific peptide (500 µM) and a putative rat
PAR4 specific activating peptide (100 µM), as measured by intracellular Ca2+-changes.
Conclusions: We have identified and characterized cDNA encoding the rat PAR4 homologue.
PAR4 is expressed predominantly in the upper gastrointestinal tract. It is activated by trypsin,
thrombin and its newly identified rat PAR4 specific activating peptide.
Background
Proteinase-activated receptors (PARs) comprise a sub-
family of G-protein coupled receptors, which are activated
by serine proteases such as trypsin and thrombin. Cleav-
age of PARs unmasks an extracellular N-terminal domain
that subsequently binds and activates the receptor, thus
acting as a tethered ligand. Four related receptors have
been identified to date [1–7]. Most recently, both human
and mouse proteinase-activated receptor 4 (AR4) have
been cloned [5,7]. Although best known for their role in
the vascular and clotting systems, PARs have also been im-
plicated as potential modulators of gastrointestinal motil-
ity [8–11] and recent studies have suggested a possible
similar role for PAR4 [10]. However, to date, the rat PAR4
homologue has not been cloned and the tissue distribu-
tion of rat PAR4 in the gastrointestinal tract is unknown.
In this report, we describe the cloning of a functional rat
PAR4 cDNA. When expressed transiently in COS-1 cells,
the rat PAR4 was activated by thrombin, trypsin, mouse
PAR4 activating peptide and its own newly identified rat
PAR4 tethered ligand. The rat PAR4 is mainly expressed in
the rat esophagus, stomach, duodenum and the spleen.
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Results
Cloning of rat PAR4
Primers, based upon the mouse PAR4 sequence, were de-
signed to amplify the rat PAR4 coding region. We ampli-
fied a 1.1-kb fragment from rat duodenal RNA of which
the nucleotide sequence shared 91 % and 82 % homology
with mouse PAR4 and human PAR4 respectively. To es-
tablish the expression and corroborate the sequence of the
PCR clone a rat duodenal cDNA library was screened. A
partial clone was identified (0.7 kb), which contained part
of the open reading frame (ORF) of the RT-PCR clone (nu-
cleotides 596–1188) and a short segment of 3' untranslat-
ed region (nucleotides 1189–1323). To fill in the missing
5' end, 5' RACE was performed. This yielded a 0.6 kb frag-
ment that represented the 5' end of the ORF (nucleotides
2–636). The ORF of the partial duodenal library clone and
the 5' RACE fragments both shared 100% homology with
the rat PAR4 PCR clone. Figure 1 shows the nucleotide se-
quence; figure 2 shows the deduced amino-acid sequence
and its alignment with the human and mouse rat PAR4
homologue. The rat PAR4 nucleotide sequence is availa-
ble in the GenBank under accession number AF310216.
Analysis of the coded amino-acid sequence revealed an
overall 90% and 75% protein identity of the rat PAR4 se-
quence with the mouse and human PAR4, respectively.
Figure 1
Nucleotide sequence of the rat PAR4 gene; CD: 1–1188.
1 ATGTGCTGGC  CGCTGCTGTA TCCTCTGATG CTCGGGTTCA  GCATCAGCCC
51 GGCGGAATGC  CAGACGCCCA  GCATCTACGA  CGATGTAGAG  AGTACCAGGG
101 AAGGCCAAGA  AGCCTCTCTG  CGTCCCACAG  TAGAACTTAA  TGAGTCGAAG
151 TCCCCAGACA  AGCCTAATCC  ACGAGGCTTC  CCGGGCAAGC  CCTGTGCCAA
201 CAACAGTGAC  ACGCTGGAGC  TCCCAGCCAG  CTCTGAAGCA  CTGCTTCTGG
251 GGTGGGTCCC  CACGAGGCTG  GTACCTGCCA  TCTATGGGCT  AGTGGTGGTC
301 GTGGGGCTGC  CTGCCAATGG  GCTAGCGCTG  TGGGTGCTGG  CCACAAGGGT
351 CCCACGCTTG  CCATCCACCA  TTCTGCTCAT  GAACCTGGCA  GTGGCTGACT
401 TGCTACTGGC  CCTGGTGCTC  CCACCACGAC  TGGTTTATCA  CCTGCGTGGC
451 CAGCGCTGGC  CGTTTGGGGA  GGCTGCCTGC  CGGGTGGCCA  CAGCTGCCCT
501 CTATGGCCAC  ATGTATGGTT  CAGTGTTGCT  GCTGGCCGCA  GTCAGCCTGG
551 ACAGATACCT  GGCCCTGGTG  CATTCTTTGC  GGGCCCGGGC  ATTGCGTGGT
601 CAACGCCTCA  CCACCATACT  CTGCTTGGTG  GCCTGGCTCT  CTGCAGCCAC
651 TCTAGTCTTG  CCACTCACGT  TTCATCGGCA  GACCTTCCTA  TTGGCTGGCT
701 CCGATCGCAT  GCTGTGTCAT  GATGCGCTGC  CATTGGCGGA  GCAGACCTCC
751 CATTGGAGAC  CGGCCTTCAT  CTGCCTGGCT  GTCCTGGGCT  GCTTTGTGCC
801 ACTGCTGGCC  ATGGTCCTGT  GCTATGGGGC  CACCCTTCGT  GCACTGGCAG
851 CCAATGGTCA  GCGGTACAGC  CATGCAGTGA  GACTGACAGC  CCTGGTCCTG
901 TTCTCAGCAG  TGGCCGCTTT  CACACCTAGC  AATGTGCTTC  TGGTGCTGCA
951 CTATTCAAAC  CCAAGCCCTG  AGGCCTGGGG  CAATCTCTAT  GGAGCCTATG
1001 TTCCCAGCCT  GGCACTCAGC  ACCCTTAACA  GCTGCGTAGA  CCCTTTCATC
1051 TACTACTATG  TGTCCCACGA  GTTCAGGGAG  AAGGTACGGG  CTATGTTGTG
1101 TCGCCAGCTG  AAGGCCAGCA  GCTCCTCTCA  GGCCTCCAGG  GAGGCTGGAA
1151 GCCGAGGGAC  TGCCATTTGC  TCCTCTACAC  TTCTGTGACT  GTTAGCTGAG
1201 TTGGGAAAGG  GGACGTTCAG  ACTCGACTGG  ATCTCCCCTT  AAACTGTCCC
1251 TCCTGAACCC  TCAGGACATG  ACCTTATTTG  GATATGCACT  TGGCGCGACC
1301 TTCATTTAGT  GGAGCTGAGG  TCCBMC Molecular Biology 2002, 3 http://www.biomedcentral.com/1471-2199/3/2
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Figure 2
Ammo-acid sequence of rat PAR4 and alignment with mouse and human PAR4 (Genbank accession number AF080215, mouse,
and AF080214, human). The putative rat PAR4 tethered ligand (GFPGKP) sequence has 3 amino-acids (GPG) in common with
the human (GYPGQV) and 4 amino-acids (GPGK) with the mouse ligand (GYPGKF). Activating peptide sequences are printed
bold.
15 0
mouse MCWP..LLYP LVLGLSISLA EGIQTPSIYD DVESTRGSHE GPLGPTVELK
rat MCWP..LLYP LMLGFSISPA E.CQTPSIYD DVESTREGQE ASLRPTVELN
human .MWGRLLLWP LVLGFSLS.. GGTQTPSVYD ESGSTGGGDD ST..PSI...
51 100
mouse EPKSSDKPNP RGYPGKFCAN DSDTLELPAS SQALLLGWVS TRLVPALYGL
rat ESKSPDKPNP RGFPGKPCAN NSDTLELPAS SEALLLGWVP TRLVPAIYGL
human ......LPAP RGYPGQVCAN DSDTLELPDS SRALLLGWVP TRLVPALYGL
101 150
mouse VVAVGLPANG LALWVLATRV PRLPSTILLT NLAVADSLLA LVPPPRLAYH
rat VVVVGLPANG LALWVLATRV PRLPSTILLM NLAVADLLLA LVLPPRLVYH
human VLVVGLPANG LALWVLATQA PRLPSTMLLM NLATADLLLA LALPPRIAYH
151 200
mouse LRGQRWPFGE AACRVATAAL YGHMYGSVLL LAAVSLDRYL ALVHPLRARA
rat LRGQRWPFGE AACRVATAAL YGHMYGSVLL LAAVSLDRYL ALVHSLRARA
human LRGQRWPFGE AACRLATAAL YGHMYGSVLL LAAVSLDRYL ALVHPLRARA
201 250
mouse LRGQRLTTGL CLVAWLSAAT LALPLTLHRQ TFRLAGSDRM LCHDALPLTE
rat LRGQRLTTIL CLVAWLSAAT LVLPLTFHRQ TFLLAGSDRM LCHDALPLAE
human LRGRRLALGL CMAAWLMAAA LALPLTLQRQ TFRLARSDRV LCHDALPLDA
251 300
mouse QTSHWRPAFI CLAVLGCFVP LLAMGLCYGA TLRALAANGQ RYSHALRLTA
rat QTSHWRPAFI CLAVLGCFVP LLAMVLCYGA TLRALAANGQ RYSHAVRLTA
human QASHWQPAFT CLALLGCFLP LLAMLLCYGA TLHTLAASGR RYGHALRLTA
301 350
mouse LVLFSAVASF TPSNVLLVLH YSNPSPEAWG NLYGAYVPSL ALSTLNSCVD
rat LVLFSAVAAF TPSNVLLVLH YSNPSPEAWG NLYGAYVPSL ALSTLNSCVD
human VVLASAVAFF VPSNLLLLLH YSDPSPSAWG NLYGAYVPSL ALSTLNSCVD
351 399
mouse PFIYYYVSHE FREKVRA.ML CRQPEASSSS QASREAGSRG TAICSSTLL
rat PFIYYYVSHE FREKVRA.ML CRQLKASSSS QASREAGSRG TAICSSTLL
human PFIYYYVSAE FRDKVRAGLF QRSPGDTVAS KASAEGGSRG MGTHSSLLQBMC Molecular Biology 2002, 3 http://www.biomedcentral.com/1471-2199/3/2
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Rat PAR4 shared 33% with rat PAR1 and 35% protein
identity with rat PAR2. Identification of a protease cleav-
age site corresponding to the human PAR4 indicated that
the putative rat PAR4 AP (GFPGKP) had 3 amino-acids
(GPG) in common with the corresponding human PAR4
(GYPGQV) and 4 amino-acids (GPGK) in common with
the mouse (GYPGKF) sequences [5,7].
Tissue distribution of rat PAR4
Northern blot analysis of poly(A)+ RNA from the duode-
num detected a 3.0 kb band (Figure 3).
This corresponds in size to the predominant band previ-
ously described in human tissues. Expression in other tis-
sues was measured by RPA (Figure 4).
Various amounts of total RNA were used based upon
availability of the tissue, however analysis of the total
amounts of PAR4 was expressed as the PAR4/actin ratio,
thereby correcting for the different amounts of total RNA.
Results showed that PAR4 is expressed at low levels in
multiple gastrointestinal tissues including the esophagus,
stomach, duodenum, jejunum and distal colon. It is also
present in the spleen.
Functional studies
COS-1 and COS-7 cells were transiently transfected with a
pcDNA3.1+ expression vector containing the rat PAR4 1.1
kb amplimer. Cells were treated with trypsin, thrombin,
mouse PAR4 AP (GYPGKF) or rat PAR4 AP (GFPGKP) and
changes in intracellular Ca2+ were measured. The reversed
sequence of the mouse PAR4 AP (FKGPYG) was used as a
control peptide, as we did not have the rat PAR4 control
peptide available. In addition, untransfected COS cells
were used as controls.
Transfected cells responded to mouse PAR4 AP 500 µM,
trypsin 1 nM, thrombin 50 nM and the putative rat PAR4
AP 100 µM (Figure 5). Control COS cells showed no re-
sponse to any agonists tested (data not shown) and trans-
fected cells failed to respond to the mouse control
peptide. After incubation with mouse PAR4 AP, the cells
did respond to a second incubation with the mouse PAR4
AP 500 µM, although the magnitude of the response was
less. Rat PAR4 AP caused an increase in intracellular Ca2+
at 100 µM. Subsequent stimulation of the receptor with
trypsin did not demonstrate an increase in intracellular
Ca2+. When these agonists were applied in reversed order,
the same observations were made: the receptor was acti-
vated by trypsin but subsequently did not respond to
stimulation with rat PAR4 AP.
Discussion
We have cloned a rat PAR cDNA from the rat duodenum.
Based on its sequence homology with the mouse and hu-
man PAR4 and its functional characteristics we conclude
that the amplimer represents the rat PAR4 homologue. Al-
though our cloning strategy involved PCR techniques in
both the initial PCR cloning of the rat PAR4 and in filling
in the partial cDNA library clone with 5' RACE, we feel
confident that the sequence of the rat receptor as reported
here, is accurate. In both cases, we used the most accurate
proofreading polymerase known, Pfu-Turbo, and in es-
sence, we independently derived two PCR clones from our
cloning experiments and found that their sequence was
identical. In addition, the rat PAR4 is fully functional in a
transient transfection assay, thus corroborating the accu-
racy of the sequence.
Synthetic peptides that mimic the tethered ligands of the
PAR receptors have been used as specific agonists to study
the function of these receptors. Site-directed mutagenesis
studies by Xu et al., who simultaneously and independ-
ently cloned the human PAR4 receptor, suggested that the
Arg-47/Gly-48 cleavage site is critical for subsequent re-
ceptor activation by thrombin and trypsin [5]. The rat
PAR4 receptor contains such a cleavage site at position
Arg-58/Gly-59. Indeed, both thrombin and trypsin func-
tion as a ligand for the rat PAR4 receptor.
The putative rat PAR4 tethered ligand contains a phenyla-
lanine in the second position, as do the human PAR1 and
PAR3. This phenylalanine in the second position of the
tethered ligand of the human PAR1 and PAR3 receptor is
critical for function of this domain and we speculate that
it is of equal importance in the rat PAR4 tethered ligand.
By contrast, in the mouse PAR4, it is a tyrosine in the sec-
ond position of the tethered ligand that is critical [7]. Fu-
Figure 3
Northern blot of rat duodenal mRNA hybridized to a rat
PAR4 probe. Left: ribosomal markers. The single hybridizing
band corresponds to a mRNA of ≅  3 kb.BMC Molecular Biology 2002, 3 http://www.biomedcentral.com/1471-2199/3/2
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ture studies, requiring the construction of different
receptor-related peptides using site-directed mutagenesis,
are needed to confirm the role of the various amino-acids
in conferring activity to the PAR4 ligand.
Although the mouse PAR4 tethered ligand (GYPGKF) dif-
fers from the putative rat PAR4 AP sequence (GFPGKP), it
was nonetheless able to activate the rat PAR4 transfected
COS cells. This may represent the ability of mouse PAR4
activating peptide to serve as a partial agonist, causing
enough of an alteration in the conformation of the recep-
tor to initiate transduction of a signal across the plasma
membrane. In keeping with this theory, in vitro studies us-
ing rat tissue have previously reported functional respons-
es to mouse PAR4 activating peptide [10,11].
When transfected COS cells were challenged with either
rat PAR4 AP or trypsin, activation occurred as demonstrat-
ed by an increase in intracellular Ca2+. However, subse-
quent stimulation with rat PAR4 AP or trypsin did not
evoke a biological response suggesting that desensitiza-
tion had occurred. It is conceivable that activation of the
receptor prevents subsequent stimulation by a second ag-
onist, analogous to studies on PAR2 mechanisms of de-
sensitization [12]. By contrast, mouse PAR4 AP did not
completely abolish a response to a second exposure to
mouse PAR4 AP, although the magnitude of the response
was less. This may be due to a weaker agonistic effect, re-
flecting differences in its sequence.
Rat PAR4 message is found mainly in the esophagus,
stomach, the duodenum and the spleen. The potential ef-
fect of PAR4 activation in the upper gastrointestinal tract
and a hematopoietic organ like the spleen is an interesting
topic for further study. Recently Andrade-Gordon et al
partially cloned guinea-pig PAR4 and identified the guin-
ea-pig activating peptide SFPGQA [14]. Guinea pig PAR4
appears to be involved in platelet aggregation. However,
the exact physiological and pathophysiological roles of
PARs in the gastrointestinal tract remains to be fully de-
fined. Several studies have suggested a role for PARs in the
modulation of gastrointestinal motility [8–10] and based
on previous literature using cross-species experiments
(mouse AP on rat GI tissue), a role for PAR4 has also been
proposed in gastric contractility [11] and in the relaxation
of esophageal muscularis mucosae [10]. The identifica-
tion of the rat PAR4 homologue, its tethered ligand and its
tissue distribution will now allow the testing of the specif-
ic PAR4 AP in various well established models of rat mo-
tility or other aspects of gastrointestinal function such as
epithelial ion transport, as has been suggested by some
studies [15].
In summary, we identified a rat PAR4 cDNA sequence
from a rat duodenal cDNA library. A putative protease
cleavage site (Arg-58/Gly-59) was identified. The rat PAR4
clone mobilized calcium in transiently transfected COS
cells in response to thrombin, trypsin, mouse PAR4 AP
and its newly identified rat PAR4 AP. The highest levels of
Figure 4
A Detection of PAR4 mRNA in rat tissues by RPA. Tissue sources are given at the top and the size of the protected fragment
is given on the left. (CM, central marker; LES, lower esophageal sphincter; IAS, internal anal sphincter; DRG, dorsal root gan-
glia). B The PAR4/actin ratio suggests that PAR4 is predominantly expressed in the esophagus, LES, and the stomach.BMC Molecular Biology 2002, 3 http://www.biomedcentral.com/1471-2199/3/2
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expression of this receptor were observed in the esopha-
gus and the stomach.
Methods
RT-PCR cloning of rat PAR4
Total RNA was made from the duodenum of normal male
Sprague-Dawley rats, using the Ultraspec™ RNA isolation
system (Biotex Laboratories, Inc., Houston, TX) and treat-
ed with DNAse I. Using the ProSTAR Ultra HF RT-PCR Sys-
tem (Stratagene, La Jolla, CA), RT-PCR was performed
with mouse PAR4 specific primers (Forward primer 5'-
ATG TGC TGG CCG CTG CTG TA-3' and reverse primer
5'-CAG TCA CAG AAG TGT AGA GG-3', Genbank acces-
sion number AF080215) which were designed to amplify
the entire coding sequence. PCR conditions were as fol-
lows: initial denaturation 95°C for 1 min (1 cycle), 95°C
for 1 min, 56°C for 1 min, 68°C for 15 min (40 cycles),
68°C final extension for 10 minutes. The PCR products
were run on a low melt agarose gel, excised and purified
with the PCR prep kit (Promega, Madison, WI) and blunt-
end ligated into a plasmid vector, pGEM 5Z(f)+ (Prome-
ga, Madison, WI). The PCR clone was completely se-
quenced using an automated ABI sequencer and its
identity as a rat PAR4 was established by alignment of its
sequence with the mouse and human PAR4 clones. To
confirm the sequence of the rat PAR4 amplimer, a rat du-
odenal cDNA library was screened.
DNA library screening
Approximately 1 ×  106 recombinant phage of a rat duode-
nal cDNA library constructed with the ZAP Express cDNA
synthesis kit (Stratagene, La Jolla, CA) were screened using
standard filter hybridization techniques with a 32P-la-
beled random primer (Prime-it II kit; Stratagene, La Jolla,
CA) rat PAR4 PCR amplimer as a probe. The filter was
washed at moderate stringency (20 min at 37°C in 2×  SSC,
0.1% SDS and for 20 min at 55°C in 0.5×  SSC, 0.1% SDS)
and subsequently exposed to Biomax film with an inten-
sifying screen overnight at -80°C. A single cDNA clone was
plaque-purified after two more rounds of screening and
Figure 5
PAR4 mediated Ca2+ mobilization in transfected COS cells. (A) Rat thrombin 50 nM (1st arrow) followed by rat PAR4 AP 100
µM (2nd arrow), (B) Trypsin 1 nM (1st arrow) followed by rat PAR4 AP 100 µM (2nd arrow), (C) Mouse PAR4 AP 500 µM fol-
lowed by repeat mouse PAR4 AP 500 µM, (D) Rat PAR4 AP 100 µM (1st arrow) followed by trypsin 1 nM (2nd and 3rd arrow),
(E) Trypsin 1 nM (1st arrow) followed by rat PAR4 AP 100 µm (2nd arrow). Thr, thrombin; trp, trypsin; ms PAR4 AP, mouse
PAR4 activating peptide.BMC Molecular Biology 2002, 3 http://www.biomedcentral.com/1471-2199/3/2
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subjected to in vivo excision as per manufacturer's proto-
col. The rat PAR4 cDNA was sequenced completely and
found to be missing 595 bases at the 5' end.
5' RACE
Rapid amplification of cDNA ends (RACE) technique was
used to complete the rat PAR4 cDNA sequence (Marathon
RACE kit, Clontech, Palo Alto, CA). Double stranded rat
duodenal cDNA was ligated to universal adapter primer
and used as a template in 5' RACE reactions. The adapter-
ligated cDNA was used in a PCR reaction with a sense
primer corresponding to the adapter primer sequence and
a PAR4 specific antisense primer (nucleotides 698–718 of
the rat PAR4 sequence). RACE PCR conditions were simi-
lar as described under RT-PCR and also performed using a
proofreading DNA polymerase (Pfu-Turbo-Stratagene La
Jolla, CA). Fragments of the expected size were run on a
low melt agarose gel, purified as described previously and
blunt-end ligated into a plasmid vector, pGEM 5Z(f)+
(Promega, Madison, WI). The identity of the PCR product
was confirmed by sequence analysis using an automated
ABI sequencer.
Northern blot analysis
mRNA was purified using the mRNA Poly(A)Pure Purifi-
cation Kit (Ambion, Austin, TX). Two µg of duodenal
mRNA was run on a 1.0 % formaldehyde-agarose gel,
transferred to a nylon membrane and UV-crosslinked. The
Northern blot was pre-hybridized and hybridized in Ex-
pressHyb (Clontech, Palo Alto, CA) at 68°C with the 32P-
labeled random primer rat PAR4 PCR-amplified DNA
clone. The membrane was washed at high stringency (20
min at 37°C in 2×  SSC, 0.1% SDS, 20 min at 65°C in 0.1
×  SSX, 0.1% SDS and exposed to Biomax film with an in-
tensifying screen overnight at -80°C.
RNAse Protection assay
The levels of rat PAR4 transcripts in a variety of rat tissues
were analyzed using a ribonuclease protection assay
(RPA). The RPA template DNA was amplified by PCR in-
corporating a T7 promoter sequence before the antisense
primer (5'CTCGGTAATACGACTCACTATAGGGAT-
GGCAAGCGTGGCACCCTTGTG-3'). The antisense ribo-
probe was labeled with alpha-[32-P] uridine triphosphate
(UTP) according to manufacturer's protocol (Maxiscript,
Ambion Inc., Austin, TX). Various amounts of total RNA
were precipitated and dissolved in 8 µl of hybridization
buffer. One microliter each of rat PAR4 (80,000 counts/
µl) and (β -actin (10,000 counts/µl) riboprobes were add-
ed to the hybridization mixture. Samples were heated to
90°C for 5 min and then hybridized at 56°C for 16 hours.
After hybridization and RNase treatment, protected frag-
ments were resolved on a 6.0 % sequencing gel. Radioac-
tive bands were quantified with Cyclone Storage Phoshor
Imaging System (Packard, Meriden, CT). PAR4 ratios were
presented against the actin band for each tissue.
Rat PAR4 functional studies
Two oligonucleotide primers were designed to amplify
the entire rat PAR4 coding region from rat duodenal RNA.
The 5' primer contained a Bam HI site and a Kozak se-
quence (5'-GCTGGTACCGGATCCGCCATGTGCT-
GGCCGCTGCTGTATCCTCTGATG-3') and the antisense
primer contained a Xba1 site (5'-
GCGTCTAGAGCGGCCGCATCACAGAAGTGTAGAG-
GAGCAAATGGCAGT-3'). The amplified PAR4 cDNA was
cleaved with the restriction enzyme Bam H1 and Xba1, di-
rectionally cloned into the expression vector pcDNA3.1+
(Invitrogen, Carlsbad, CA) and its sequence verified. For
the tranfection, COS-7 cells and COS-1 cells were grown
in DMEM with 10% fetal bovine serum (FBS) supple-
mented with penicillin/streptomycin. Cells were plated 1
day before transfection. PAR4 DNA (1 µg) was cotrans-
fected with green fluorescent protein (GFP) according to
manufacturer's protocol (FuGene™ 6 Transfection Rea-
gent; Roche, Indianapolis, IN) and the cells were incubat-
ed for 36–48 hours. The cells were then loaded with the
calcium indicator fura-2 and [Ca2+]i-mobilization was
measured using the 340/380 ratio. Specific PAR4 agonists
were used including trypsin (Sigma, St. Louis, MO), rat
thrombin (Sigma, St. Louis, MO) and rat and mouse PAR4
AP. (rat PAR4, GFPGKP-NH2; mouse PAR4, GYPGKF-
NH2; reversed mouse PAR4, FKGPYG-NH2. All peptides
were synthesized at the UTMB Core Protein Facility using
standard solid phase synthesis procedures).
Abbreviations
PAR, proteinase-activated receptor; RPA, ribonuclease
protection assay; AP, activating peptide; ORF, open read-
ing frame
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